title: [Celecoxib and the CLASS study--a statement].
authors.affiliation: Pharmacia Norge AS Lilleakerveien 2 B 0283 Oslo.
authors.forename: Einar
authors.initials: E
authors.lastname: Wibe
authors.forename: Sverre
authors.initials: S
authors.lastname: Maehlum
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D004345:Drug Industry; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib